<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rgen" ></link>
<id>urn:uuid:18f1ec09-6282-7f44-d373-fe7f907c429f</id>
<updated>2026-11-10T22:53:54-05:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RGEN: DOUGLASS BRIAN ROBB (O) Acquired (JB) 700 Shares of REPLIGEN CORP for $0.00 on 10/6</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6479466" ></link>
<id>urn:uuid:d2db4f2d-06b1-5677-b48f-2b232836fbec</id>
<updated>2026-10-08T16:40:07-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Exercised 4,202 Options (OE) of REPLIGEN CORP for $154.96 on 10/5, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6478560" ></link>
<id>urn:uuid:bd6c0190-60db-10f3-7314-f01f22e89ebd</id>
<updated>2026-10-06T16:18:26-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Disposed (JS) 1,248 Shares of REPLIGEN CORP for $181.70 on 10/2</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6477312" ></link>
<id>urn:uuid:4b67a638-5eea-c489-9025-e4543c980fba</id>
<updated>2026-10-05T16:01:21-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: GARLAND JASON K (CFO) Disposed (JS) 421 Shares of REPLIGEN CORP for $189.68 on 9/25</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6473974" ></link>
<id>urn:uuid:e4313e83-04d8-06e0-d690-3f4b9c0b0cab</id>
<updated>2026-09-28T16:05:54-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Exercised 12,946 Options (OE) of REPLIGEN CORP for $154.96-$155.38 on 9/24, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6473561" ></link>
<id>urn:uuid:14b7442d-e748-58fe-e131-9f2e34d4dbc0</id>
<updated>2026-09-25T16:09:43-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Exercised 5,426 Options (OE) of REPLIGEN CORP for $141.79 on 9/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6472336" ></link>
<id>urn:uuid:b11044a5-ab15-3fcf-02a5-bdc03afed111</id>
<updated>2026-09-22T16:07:23-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Sold (AS) 3,035 Shares of REPLIGEN CORP for $165.90 on 9/4</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6466088" ></link>
<id>urn:uuid:f56493ca-1a0b-dde9-9b4f-798d7e823631</id>
<updated>2026-09-08T16:13:40-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $173.49. Mkt Cap:11.1B. 10D Vol: 1.6mm]]></summary>
</entry>
</feed>